Cargando…
Type 2 inflammation modulates ACE2 and TMPRSS2 in airway epithelial cells
BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has dramatically changed our world, country, communities, and families. There is controversy regarding risk factors for severe COVID-19 disease. It has been suggested that asthma and allergy are not highly represented as comorb...
Autores principales: | Kimura, Hiroki, Francisco, Dave, Conway, Michelle, Martinez, Fernando D., Vercelli, Donata, Polverino, Francesca, Billheimer, Dean, Kraft, Monica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mosby
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227558/ https://www.ncbi.nlm.nih.gov/pubmed/32422146 http://dx.doi.org/10.1016/j.jaci.2020.05.004 |
Ejemplares similares
-
The OM-85 bacterial lysate inhibits SARS-CoV-2 infection of epithelial cells by downregulating SARS-CoV-2 receptor expression
por: Pivniouk, Vadim, et al.
Publicado: (2022) -
Down syndrome: the aggravation of COVID-19 may be partially justified by the expression of TMPRSS2
por: Evangelho, Victor Gustavo Oliveira, et al.
Publicado: (2021) -
ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to
SARS-COV-2 in Cancer Patients
por: Ravaioli, Sara, et al.
Publicado: (2020) -
Involvement of Spike Protein, Furin, and ACE2 in SARS-CoV-2-Related Cardiovascular Complications
por: Ming, Yi, et al.
Publicado: (2020) -
Increased ACE2 Expression in Bronchial Epithelium of COPD Patients who are Overweight
por: Higham, Andrew, et al.
Publicado: (2020)